Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.

Marques I, Teixeira AL, Ferreira M, Assis J, Lobo F, Maurício J, Medeiros R.

Mol Biol Rep. 2013 Aug;40(8):4819-26. doi: 10.1007/s11033-013-2578-3. Epub 2013 May 5.

PMID:
23645041
[PubMed - indexed for MEDLINE]
2.

Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.

Qin C, Cao Q, Li P, Ju X, Wang M, Chen J, Wu Y, Meng X, Zhu J, Zhang Z, Lu Q, Yin C.

PLoS One. 2012;7(1):e28829. doi: 10.1371/journal.pone.0028829. Epub 2012 Jan 25.

PMID:
22295057
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.

Theodoropoulos GE, Gazouli M, Vaiopoulou A, Leandrou M, Nikouli S, Vassou E, Kouraklis G, Nikiteas N.

Int J Colorectal Dis. 2011 Sep;26(9):1113-8. doi: 10.1007/s00384-011-1217-5. Epub 2011 May 3.

PMID:
21538054
[PubMed - indexed for MEDLINE]
4.

GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.

Arjumand W, Ahmad ST, Nafees S, Ali N, Rashid S, Seth A, Sultana S.

Genet Test Mol Biomarkers. 2012 Sep;16(9):1062-6. doi: 10.1089/gtmb.2012.0047. Epub 2012 Aug 29.

PMID:
22931242
[PubMed - indexed for MEDLINE]
5.

The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.

de Martino M, Haitel A, Schatzl G, Klingler HC, Klatte T.

J Urol. 2013 Aug;190(2):717-22. doi: 10.1016/j.juro.2013.01.008. Epub 2013 Jan 9.

PMID:
23313206
[PubMed - indexed for MEDLINE]
6.

[A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].

Lou Y, Fang CQ, Li JH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):59-62. Chinese.

PMID:
17285546
[PubMed - indexed for MEDLINE]
7.

The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.

Bayram S, Akkız H, Bekar A, Akgöllü E.

Cancer Epidemiol. 2011 Dec;35(6):555-9. doi: 10.1016/j.canep.2011.01.004. Epub 2011 Feb 5.

PMID:
21296634
[PubMed - indexed for MEDLINE]
8.

Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.

Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G.

PLoS One. 2011 Feb 3;6(2):e16748. doi: 10.1371/journal.pone.0016748.

PMID:
21304814
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.

Hmeljak J, Erčulj N, Dolžan V, Kern I, Cör A.

J Cancer Res Clin Oncol. 2011 Nov;137(11):1641-51. doi: 10.1007/s00432-011-1030-0. Epub 2011 Aug 23.

PMID:
21861135
[PubMed - indexed for MEDLINE]
10.

[Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].

Ni Q, Jiang X, Jin MJ, Liu B, Chen K.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):318-22. doi: 10.3760/cma.j.issn.1003-9406.2011.03.018. Chinese.

PMID:
21644232
[PubMed - indexed for MEDLINE]
11.

Caspase 9 promoter polymorphisms confer increased susceptibility to breast cancer.

Theodoropoulos GE, Michalopoulos NV, Pantou MP, Kontogianni P, Gazouli M, Karantanos T, Lymperi M, Zografos GC.

Cancer Genet. 2012 Oct;205(10):508-12. doi: 10.1016/j.cancergen.2012.08.001. Epub 2012 Sep 13.

PMID:
22981751
[PubMed - indexed for MEDLINE]
12.

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.

Clin Cancer Res. 2007 Jul 15;13(14):4123-9.

PMID:
17634539
[PubMed - indexed for MEDLINE]
Free Article
13.

Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.

Audenet F, Cancel-Tassin G, Bigot P, Audouin M, Gaffory C, Ondet V, Thibault F, Auribault K, Gazut S, Benhabiles N, Azzouzi AR, Méjean A, Rouprêt M, Cussenot O.

J Urol. 2014 Feb;191(2):487-92. doi: 10.1016/j.juro.2013.07.064. Epub 2013 Aug 1.

PMID:
23911636
[PubMed - indexed for MEDLINE]
14.

Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.

Liamarkopoulos E, Gazouli M, Aravantinos G, Tzanakis N, Theodoropoulos G, Rizos S, Nikiteas N.

Gastric Cancer. 2011 Oct;14(4):317-21. doi: 10.1007/s10120-011-0045-1. Epub 2011 Apr 2.

PMID:
21461653
[PubMed - indexed for MEDLINE]
15.

Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.

Cai C, Wang LH, Dong Q, Wu ZJ, Li MY, Sun YH.

Tissue Antigens. 2013 Sep;82(3):165-70. doi: 10.1111/tan.12170.

PMID:
24032722
[PubMed - indexed for MEDLINE]
16.

Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.

Andric M, Nikolic N, Boskovic M, Milicic B, Skodric S, Basta Jovanovic G, Milasin J.

Eur J Oral Sci. 2012 Feb;120(1):9-13. doi: 10.1111/j.1600-0722.2011.00919.x.

PMID:
22288915
[PubMed - indexed for MEDLINE]
17.

IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.

Zhu J, Qin C, Yan F, Wang M, Ding Q, Zhang Z, Yin C.

Int J Urol. 2010 Aug;17(8):700-7. doi: 10.1111/j.1442-2042.2010.02559.x. Epub 2010 Jun 1.

PMID:
20529140
[PubMed - indexed for MEDLINE]
18.

Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.

Li XB, Li SN, Yang ZH, Cao L, Duan FL, Sun XW.

DNA Cell Biol. 2013 May;32(5):236-42. doi: 10.1089/dna.2012.1912. Epub 2013 Apr 12.

PMID:
23581553
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population.

Liu H, Jiang X, Zhang MW, Pan YF, Yu YX, Zhang SC, Ma XY, Li QL, Chen K.

J Zhejiang Univ Sci B. 2013 Jan;14(1):47-57. doi: 10.1631/jzus.B1200218.

PMID:
23303631
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.

Chang WS, Ke HL, Tsai CW, Lien CS, Liao WL, Lin HH, Lee MH, Wu HC, Chang CH, Chen CC, Lee HZ, Bau DT.

Anticancer Res. 2012 Sep;32(9):3855-60.

PMID:
22993329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk